Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v42-EN | Version v19-EN | |
---|---|---|
Language | English | English |
Date Updated | 2018-05-29 | 2018-04-05 |
Drug Identification Number | 02238525 | 02238525 |
Brand name | HP-PAC | HP-PAC |
Common or Proper name | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN |
Company Name | TAKEDA PHARMACEUTICALS AMERICA INC | TAKEDA PHARMACEUTICALS AMERICA INC |
Ingredients | AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN | AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN |
Strength(s) | 500MG 30MG 500MG | 500MG 30MG 500MG |
Dosage form(s) | KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET | KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET |
Route of administration | ORAL | ORAL |
Packaging size | Blister pack | Blister pack |
ATC code | A02BD | A02BD |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2018-04-19 | |
Actual start date | 2018-05-07 | |
Estimated end date | 2018-06-22 | 2018-05-30 |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |